Scientific Opinion on the safety of chromium picolinate as a source of chromium added for nutritional purposes to foodstuff for particular nutritional uses and to foods intended for the general population

EFSA Journal

Volumn 8, Issue 12, 2010, Pages

[No Author Info available]

Author keywords

CAS Registry Number 14639 25 9; chromium picolinate; Food supplements

Indexed keywords

EID: 84862206719     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2010.1883     Document Type: Article

References (144)

1. Abdulla M, Behbehani A and Dashti H, 1989. Dietary intake and bioavailability of trace elements. Biological Trace Element Research 21, 173–178.
2. Althuis MD, Jordan NE, Ludington EA and Wittes JT, 2002. Glucose and insulin responses to dietary chromium supplements: a meta- analysis. The American Journal of Clinical Nutrition 76, 148–269.
3. Amato P, Morales AJ and Yen SS, 2000. Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body composition in healthy, nonobese, older men and women. The Journal of Gerontology. Series A, Biological Sciences and Medical Sciences 55, M260–M263.
4. Anderson RA and Kozlovsky AS, 1985. Chromium intake, absorption and excretion of subjects consuming self-selected diets. The American Journal of Clinical Nutrition 41, 1177–1183.
5. Anderson RA, Polansky MM, Bryden NA and Canary JJ, 1991. Supplemental-chromium effects on glucose, insulin, glucagon, and urinary chromium losses in subjects consuming controlled low-chromium diets. The American Journal of Clinical Nutrition 54, 909–916.
6. Anderson RA, Bryden NA, Polansky MM and Gautschi K, 1996. Dietary chromium effects on tissue chromium concentrations and chromium absorption in rats. The Journal of Trace Elements in Experimental Medicine 9, 11–25.
7. Anderson RA, 1997. Chromium as an essential nutrient for humans. Regulatory Toxicology and Pharmacology 26, S35–S41.
8. Anderson RA, Cheng N, Bryden NA, Polansky MM, Cheng N, Chi J and Feng J, 1997a. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type II diabetes. Diabetes 46, 1786–1791.
9. Anderson RA, Bryden NA and Polansky MM, 1997b. Lack of toxicity of chromium chloride and chromium picolinate in rats. Journal of the American College of Nutrition 16, 273–279.
10. Anderson RA, 1998. Chromium, glucose intolerance and diabetes. Journal of the American College of Nutrition 17, 548–555.
11. Andersson MA, Petersson-Grawe KV, Karlsson OM, Abramsson-Zetterberg LAG and Hellman BE, 2007. Evaluation of the potential genotoxicity of chromium picolinate in mammalian cells in vivo and in vitro. Food and Chemical Toxicology 45, 1097–1106.
12. ATSDR (Agency for Toxic Substances & Disease Registry), 2000. Toxicological Profile for Chromium. Centers for Disease Control and Prevention (CDC), Agency for Toxic Substances and Disease Registry (ATSDR), Atlanta, Georgia. Available from: www.atsdr.cdc.gov/toxprofiles/tp7.pdf.
13. Bagchi D, Bagchi M, Balmoori J, Ye X and Stohs SJ, 1997. Comparative Induction of Oxidative Stress in Cultured J774A.1 Macrophage Cells by Chromium Picolinate and Chromium Nicotinate. Research Communications in Molecular Pathology Pharmacology 97, 335–346.
14. Bahadori B, Wallner S, Hacker C, Boes U, Komorowski JR and Wascher TC, 1999. Effects of chromium picolinate on insulin levels and glucose control in obese patients with Type-II diabetes mellitus. Diabetes 48, A349.
15. Bailey MM, Boohaker J, Sawyer R, Behling J, Rasco J, Jernigan J, Hood R and Vincent J, 2006. Exposure of pregnant mice to chromium picolinate results in skeletal defects in their offspring. Birth Defects Research (Part B) 77, 244–249.
16. 2O)3]+, in mice. Birth Defects Research (Part B) 83, 27–31.
17. Bailey MM, Boohaker JG, Jernigan PL, Townsend MB, Sturdivant J, Rasco JF, Vincent JB and Hood RD, 2008b. Effects of pre- and postnatal exposure to chromium picolinate or picolinic acid on neurological development in CD-1 mice. Biological Trace Elements Research 124, 79–82.
18. Barberá M, Farré R, Lozano A, 1989. Oral intake of cadmium, lead, cobalt, chromium, nickel, copper, manganese and zinc in Spanish diet, estimated by a duplicate meal study. Journal of Micronutrient Analysis 6, 47–57.
19. BDL, 1995. Evaluation of Chromium(III) picolinate in the Ames/Salmonella Mutagenicity Assay. Prepared by Biodevelopment Laboratories, Inc. for Nutrition 21, San Diego, Calif.; [BDL Reference Number 30101].
20. Berner TO, Murphy MM and Slesinski R, 2004. Determining the safety of chromium tripicolinate for addition to foods as a nutrient supplement. Food and Chemical Toxicology 42, 1029–1042.
21. BfR (Bundesinstitut für Risikobewertung), 2004. Verwendung von Mineralstoffen in Lebensmitteln Toxikologische und ernährungsphysiologische Aspekte Teil II. Bundesinstitut für Risikobewertung (BfR) (Federal Institute for Risk Assessment), Berlin, Germany. Available from: www.bfr.bund.de/cm/238/verwendung_von_mineralstoffen_in_lebensmitteln_bfr_wissenschaft_4_2004.pdf.
22. Bowden JP, Chung KT and Andrews AW, 1976. Mutagenic activity of tryptophan metabolites produced by rat intestinal flora. Journal of the National Cancer Institute 57, 921–924.
23. Boyd GS, Boone BE, Smith AR, Conners J and Dohm GL, 1998. Combined dietary chromium picolinate supplementation and an exercise program leads to a reduction of serum cholesterol and insulin in college-aged subjects. The Journal of Nutritional Biochemistry 9, 471–475.
24. Campbell WW, Beard JL Joseph LJ, Davey SL, Evans WJ, 1997. Chromium picolinate supplementation and resistive training by older man; effects on iron-status and hematologic indexes. American Journal of Clinical Nutrition 66, 944–949.
25. Cefalu WT, Wang ZQ, Zhang XH, Baldor LC and Russell JC, 2002. Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats. Journal of Nutrition 132, 1107–1114.
26. Cerulli J, Grabe DW, Gauthier I, Malone M and McGoldrick MD, 1998. Chromium picolinate toxicity. The Annals of Pharmacotherapy 32, 428–431.
27. Cheng N, Zhu X, Hongli S, Wo W, Chi J, Cheng J and Anderson R, 1999. Follow-up survey of people in China with type II diabetes mellitus consuming supplemental chromium. Journal of Trace Elements in Medicine and Biology 12, 55–60.
28. Codex Alimentarius Commission, 1997. Codex Standard for Natural Mineral Waters. Codex Alimentarius Commission, Rome, Italy; [Codex Stan 108–1981 Rev 1–1997]. Available from: www.codexalimentarius.net/download/standards/223/CXS_108e.pdf.
29. COM (Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment), 2004. Statement on the Mutagenicity of Trivalent Chromium and Chromium Picolinate. U.K. Department of Health. Committee on Mutagenicity (COM) [Committees on Toxicity, Mutagenicity, Carcinogenicity of Chemicals in Food, Consumer Products and the Environment], London, Engl.; [COM/04/S3]. Available from: www.advisorybodies.doh.gov.uk/com/chromium.htm.
30. COMA (UK Committee on Medical Aspects of Food Policy), 1991. Chromium. In Dietary Reference Values for Energy and Nutrients for the United Kingdom. Report of the Dietary Reference Values of the Committee on Medical Aspects of Food Policy. U.K. Department of Health, Committee on Medical Aspects of Food Policy (COMA) / Her Majesty's Stationary Office (HMSO), London, Engl. Report on Health and Social Subjects No. 41, pp. 181–182.
31. Conn LW, Webster HL, Johnson AH, 1932. Chromium toxicology absorption of chromium by the rat when milk containing chromium was fed. American Journal of Hygiene 15, 760–765.
32. Coryell VH and Stearns DM, 2006. Molecular analysis of hprt mutations induced by chromium picolinate in CHO AA8 cells. Mutation Research 610, 114–23.
33. D-A-CH Referenzwerte, 2000. Deutsche Gesellschaft für Ernährung, Österreichische Gesellschafter für Ernährung, Schweizerische Gesellschafter für Ernährungsforschung, Schweizerische Vereinigung für Ernährung: Referenzwerte für die Nährstoffzufuhr, Umschau/Braus Verlag.
34. Eastmond DA, Macgregor JT and Slesinski RS, 2008. Trivalent Chromium: Assessing the genotoxic risk of an essential trace element and widely used human and Animal Nutritional supplement. Critical Reviews in Toxicology 38, 173–190.
35. EFSA (European Food Safety Authority), 2005. Opinion of the scientific committee on a request from EFSA related to a harmonised approach for risk assessment of substances which are both genotoxic and carcinogenic (Questions No EFSA-Q-2004-020). Adopted on 18 October 2005. The EFSA Journal, 282, 1–30. Available from: www.efsa.europa.eu/en/science/sc_commitee/sc_opinions/1201.html.
36. EFSA (European Food Safety Authority), 2009a. Chromium picolinate, zinc picolinate and zinc picolinate added for nutritional purposes in food supplements. Scientific Opinion of the Panel on Food Additives and Nutrient Sources added to Food (Questions No EFSA-Q-2005-077, EFSA-Q-2006-231, EFSA-Q-2005-094, EFSA-Q-2005-110). Adopted on 4 June 2009. The EFSA Journal, 1113, 1–41. Available from: www.efsa.europa.eu/en/scdocs/doc/ans_ej1113_Chromium_picolinate_op_en.pdf.
37. EFSA (European Food Safety Authority), 2009b. Chromium(III) lactate trihydrate as a source of chromium added for nutritional purposes to food supplements. Scientific Opinion of the Panel on Food Additives and Nutrient Sources added to Food (Questions No EFSA-Q-2006-307). Adopted on 2 June 2009. The EFSA Journal, 1112, 1–20. Available from: www.efsa.europa.eu/en/scdocs/doc/1112.pdf.
38. EFSA (European Food Safety Authority), 2009c. Chromium nitrate as a source of chromium added for nutritional purposes to food supplements. Scientific Opinion of the Panel on Food Additives and Nutrient Sources added to Food (Questions No EFSA-Q-2005-216). Adopted on 2 June 2009. The EFSA Journal, 1111, 1–19. Available from: www.efsa.europa.eu/en/scdocs/doc/1111.pdf.
39. EFSA (European Food Safety Authority), 2010. Scientific Opinion on the safety of trivalent chromium as a nutrient added for nutritional purposes to foodstuffs for particular nutritional uses and foods intended for the general population (including food supplements). Scientific Opinion of the Panel on Food Additives and Nutrient Sources added to Food (Question N$ EFSA-Q-2009-00870). Adopted on 10 November 2010. The EFSA Journal, 8(11).
40. EPA US (Environmental Protection Agency), 1998. Toxicological Review of Trivalent Chromium (CAS No. 16065-83-1). National Center for Environmental Assessment, Office of Research and Development, Washington, DC. Available from: www.epa.gov/NCEA/iris/toxreviews/0028tr.pdf.
41. Esber H, Moreno V and Loveday KS, 1997. Evaluation of chromium picolinate in the Ames and the rat in vivo of chromosomal aberration assays. Mutation Research 379, S89 [Abstract No. PXII.15].
42. Evans GW, 1989. The effect of chromium picolinate on insulin controlled parameters in humans. International Journal of Biosocial and Medical Research 11, 163–80.
43. Evans GW, 1993. Chromium picolinate is an efficacious and safe supplement. International Journal of Sport Nutrition 3, 117–122.
44. EVM (Expert Group on Vitamins and Minerals), 2002. Review of chromium. Paper for discussion prepared by the UK Department of Health and MAFF, EVM/99/26, revised August 2002, London. www.food.gov.uk/multimedia/pdfs/reviewofchrome.pdf#page=1.
45. EVM (Expert Group on Vitamins and Minerals), 2003. Risk assessment: Chromium. In: Safe Upper Levels for Vitamins and Minerals. Report on the Expert Group on Vitamins and Minerals (EVM). U.K. Food Standards Agency (FSA), Committee on Nutrition (SACN), Expert Group on Vitamins and Minerals (EVM), London, Engl.; pp. 172–179. Available from: www.food.gov.uk/multimedia/pdfs/vitmin2003.pdf.
46. Feng J, Lin D, Zheng A and Cheng N, 2002. Chromium picolinate reduces insulin requirement in people with type 2 diabetes mellitus. Diabetes 51, A469.
47. Finch MR, Sack DA, Docherty J and Komorowski JR, 2004. Evaluation of safety in a clinical trial studying the effects of chromium picolinate on atypical depression. International Journal of Toxicology 23, 399.
48. Friedman J, Shabtai F, Levy LS and Djaldetti M, 1987. Chromium chloride induces chromosomal aberrations in human lymphocytes via indirect action. Mutat. Res. 191, 207–210.
49. FSA (UK Food Satdard Agency), 2004. Agency Revises Chromium Picolinate Advice. Food Standards Agency (FSA), London, Engl.; [Press release issued December 13, 2004]. Available from: www.food.gov.uk/news/newsarchive/2004/dec/chromiumupdate.
50. FSA (UK Food Satdard Agency), 2008. Chromium. Food Standards Agency (FSA). Eat Well, Be Well – Helping You Make Heathier Choices, London, Engl. Available from: www.eatwell.gov.uk/healthydiet/nutritionessentials/vitaminsandminerals/chromium/?lang=gn.
51. Gammelgaard B, Jensen K and Steffansen B, 1999. In vitro metabolism and permeation studies in rat jejunum: Organic chromium compared to inorganic chromium. Journal of Trace Elements in Medicine and Biology 13, 82–88.
52. Garcia E, Cabrera C, Lorenzo ML, Sánchez J and López MC, 2001. Daily dietary intake of chromium in southern Spain measured with duplicate diet sampling. The British Journal of Nutrition 86, 391–6. Cited In: SCF, 2003b.
53. Gargas ML, Norton RL, Paustenbach DJ and Finley BL, 1994. Urinary excretion of chromium by humans following ingestion of chromium picolinate. Implications for biomonitoring. Drug Metabolism and Disposition 22, 522–529.
54. Ghosh D, Bhattacharya B, Mukherjee B and Manna B, 2002. Role of chromium supplementation in Indians with type II diabetes mellitus. The Journal of Nutritional Biochemistry 13, 690–697.
55. Grant KE, Chandler RM, Castle AL and Ivy JL, 1997. Chromium and exercise training: effect on obese women. Medicine and Science in Sports and Exercise 29, 992–998.
56. Greenberg D, Komorowski JR and Loveday KJ, 1999. Rat chromosomes are unharmed by orally administered chromium picolinate. Journal of the American College of Nutrition 18, 27. Cited in: COM, 2004.
57. Gudi R, Slesinski RS, Clarke JJ and San RH, 2005. Chromium picolinate does not produce chromosome damage in CHO cells. Mutation Research 587, 140–146.
58. Hagen CD, Lindemann MD and Purser KW, 2000. Effect of dietary chromium tripicolinate on productivity of sows under commercial conditions. Swine Health and Production 8, 59–63.
59. Hepburn DDD, Vincent JB, 2002. In vivo distribution of chromium from chromium picolinate in rats and implications for the safety of the dietary supplement. Chemical Research in Toxicology 15, 93–100.
60. Hepburn DDD, Xiao J, Bindom S, Vincent JB and O'Donnell J, 2003. Nutritional supplement chromium picolinate causes sterility and lethal mutations in Drosophila melanogaster. Proceedings of the National Academic Sciences USA 100, 3766–3771.
61. Hininger I, Benaraba R, Osman M, Faure H, Roussel A-M and Anderson RA, 2007. Safety of trivalent chromium complexes: No evidence for DNA damage in human HaCaT keratinocytes. Free Radical Biology and Medicine 42, 1759–1765.
62. Houweling S, Kleefstra N, Jansman FGA, Baker S, Groenier K, Meyboom-de Jong and Bilo H, 2003. Effects of chromium treatments in patients with poorly controlled insulin-treated Type 2 dieabetes mellitus. A randomized, double-blind, placebocontrolled trial. Diabetologia 46, A261.
63. IARC (International Agency for Research on Cancer), 1980. Chromium and chromium compounds. In: Some Metals and Metallic Compounds, 205–323. Lyon (France).
64. IARC (International Agency for Research on Cancer), 1990. Chromium and chromium compounds. In: Chromium, nickel and welding. IARC Working Group. June 5–13, 1989, Lyon, France. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 49, 49–256. IARC Scientific Publications.
65. IOM (Institute of Medicine), 2001 Chromium. In: Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium and Zinc. Panel on Micronutrients, Subcommittees on Upper Reference Levels of Nutrients and of Interpretation and Use of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine (IOM). National Academy Press (NAP), Washington, DC; pp. 197–223. Available from: books.nap.edu/openbook.php?record_id=10026&page=197.
66. IOM (Institute of Medicine), 2004. Prototype Monograph on Chromium Picolinate. National Academy Press (NAP)/ National Academy of Sciences, Panel on Micronutrients, Food and Nutrition Board, Institute of Medicine (IOM), Washington, DC; 2004. Available from: www.iom.edu/Object.File/Master/19/558/0.pdf.
67. IPCS (International Programme on Chemical Safety), 1988. Chromium. Environmental Health Criteria 61. World Health Organisation. Geneva.
68. Ivankovic S and Preussmann R, 1975. Absence of toxic and carcinogenic effects after administration of high doses of chromic oxide pigment in subacute and long-term feeding experiments in rats. Food and Cosmetics Toxicology 13, 347–351.
69. Jana, M, Rajaram A, 2009. “Chromium picolinate induced apoptosis of lymphocytes and the signalling mechanisms thereof.” Toxicology and Applied Pharmacology 237(3), 331–44.
70. Jovanovic-Peterson L, Gutierrez M and Peterson CM, 1999. Chromium supplementation for women with gestational diabetes mellitus. Journal of Trace Elements in Medicine and Biology 12, 91–97.
71. Jeejeebhoy KN, 1999. The role of chromium in nutrition and therapeutics and as a potential toxin. Nutrition Reviews 57, 329–335.
72. Joseph LJ, Farrell PA, Davey SL, Evans WJ, Campbell WW, 1999. Effect of resistance training with or without chromium picolinate supplementation on glucose metabolism in older men and women. Metabolism 48, 546–553.
73. Jovanovic-Peterson L, Gutierrez M and Peterson CM, 1999. Chromium supplementation for women with gestational diabetes mellitus. Journal of Trace Elements in Medicine and Biology 12, 91–97.
74. Juturu V and Komorowski JR, 2002. Antimutagenic activity of chromium picolinate in the Salmonella assay. Pharmacologist Supplement 44, A59 [Abstract No. 38.2].
75. Juturu V and Komorowski JR, 2003. Different forms of chromium: A critical evaluation of absorption and excretion. FASEB Journal 17, A1129 [Abstract No. 703.1].
76. Juturu V, Siesinshi RS, Gudi R, San R and Komorowshi JR, 2004. Chromium picolinate does not produce chromosome damage in the in vitro mammalian chromosome abberation test with CHO cells. Environmental and Molecular Mutagenesis 44, 208 [Abstract No. 87].
77. Kareus SA, Kelley C, Walton HS and Sinclair PR, 2001. Release of Cr(III) from Cr(III) picolinate upon metabolic activation. Journal of Hazardous Materials 84, 163–174.
78. Kato I, Vogelman JH, Dilman V et al., 1998. Effect of supplementation with chromium picolinate on antibody titers to 5-hydroxymethyl uracil. European Journal of Epidemiology 14, 621–626.
79. Kim DS, Kim TW, Park IK, Kang JS and Om AS, 2002. Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body weight in dexamethasone-treated rats. Metabolism 51, 589–594.
80. Kim DS, Kim TW and Kang JS, 2004. Chromium picolinate supplementation improves insulin sensitivity in Goto-Kakzaki diabetic rats. Journal of Trace Elements in Medicine and Biology 17, 243–247.
81. Kiopes L, 1999. Evaluation of Chromium Picolinate in the Rat in Vivo Chromosomal Aberration Assay. Prepared by Primedica Corporation, Mass. For AMBI Inc., Purchase, New York; [Reference Number 30102].
82. Kirpnick-Sobol Z, Reliene R and Schiestl RH, 2006. Carcinogenic Cr(VI) and the Nutritional Supplement Cr(III) Induce DNA Deletions in Yeast and Mice. Cancer Research 66, 3480–3484.
83. Klaassen CD (Ed.), 2008. [Chromium]. In: Casarett and Doull's Toxicology: The Basic Science of Poisons, 7th ed. McGraw-Hill Health Professions Division, New York/Toronto; 942–943 and relevant refs.
84. Komorowski JR, Greenberg D and Juturu V, 2008. Chromium picolinate does not produce chromosome damage. Toxicology in vitro 22, 819–826.
85. Lamson DS, Plaza SM, 2002. The safety and efficacy of high-dose chromium. Alternative Medicine Review 7, 218–235.
86. Lee NA and Reasner CA, 1994. Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care 17, 1449–1452.
87. Léonard A and Lauwerys RR, 1980. Carcinogenicity and mutagenicity of chromium. Mutation Research 76, 227–239.
88. Levina A and Lay P, 2008. Chemical properties and toxicity of chromium(III) nutritional supplements. Chemical Research in Toxicology 21, 563–571.
89. Levis AG, Bianchi V, Tamino G and Pegoraro B, 1978. Cytotoxic Effects of Hexavalent and Trivalent Chromium On Mammalian Cells In Vitro. British Journal of Cancer 37, 387–396.
90. Lindemann MD, Wood CM, Harper AF, Kornegay ET and Anderson RA, 1995. Dietary chromium picolinate additions improve gain:feed and carcass characteristics in growing-finishing pigs and increase litter size in reproducing sows. Journal of Animal Science 73, 457–465.
91. Lindemann MD, Carter SD, Chiba LI, Dove CR, LeMieux FM and Southern LL, 2004. A regional evaluation of chromium tripicolinate supplementation of diets fed to reproducing sows. Journal of Animal Science 82, 2972–2977.
92. MacKenzie RD, Byerrum RU, Decker CF, Hoppert CA and Langham RF, 1958. Chronic toxicity studies: II. Hexavalent and trivalent chromium administered in drinking water to rats. A.M.A. Archives of Industrial Health 18, 232–234.
93. Martin A (Guest ed.-in-chief), 2001. Micronutrients. 1.12. Chromium. In: Nutritional Recommendations for the French Population: > Apports Nutritionnels Conseillés < (ANCs) (English condensed ed.). Lavoisier, Paris. Sciences des Aliments Sciences des Aliments 21, 4, 391–392.
94. Martin WM and Fuller RE, 1998. Suspected chromium picolinate induced rhabdomyolysis. Pharmacotherapy 18, 860–862.
95. Mennen B, 1997. Over-the counter chromium and renal failure. Annals of Internal Medicine 127, 655–656.
96. Michelfelder HJ, Thompson J and Shepherd M, 1997. Over-the –counter chromium and renal failure. Annals of Internal Medicine 127, 655.
97. Morris BW, Kouta S, Robinson R, MacNeil S and Heller S, 2000. Letters: Chromium supplementation improves insulin resistance in patients with Type 2 diabetes mellitus. Diabetic Medicine 17, 684–685.
98. Norseth T, 1981. The Carcinogenicity of Chromium. Environmental Health Perspectives 40, 121–130.
99. NTP (US National Toxicology Programme), 1999. Combined Summary Report (1500). Frequency of Micronuclei in Erythrocytes Following Administration of Chromium Picolinate Monohydrate by GAV (a). Department of Health and Human Services (DHHS). National Toxicology Program (NTP), Research Triangle Park, North Carolina. Unpublished Report. Cited in: NTP, 2009.
100. NTP (US National Toxicology Programme), 2008. NTP Technical Report on the Toxicology and Carcinogenesis Studies of Chromium Picolinate Monohydrate (CAS No. 27882-76-4) in F344/N Rats and B6C3F1 Mice (Feed Studies): DRAFT. Department of Health and Human Services (DHHS). National Toxicology Program (NTP), Research Triangle Park, North Carolina. NTP Technical Report Series, No. 556. Abstract available from: ntp.niehs.nih.gov/index.cfm?objectid=6A4A18CB-F1F6-975E-72D4856D552E4068. Full Draft available from: http://ntp.niehs.nih.gov/files/TR556board_webRev.pdf. NTP Testing Status: Chromium Picolinate Monohydrate M010098: CASRN: 27882-76-4. National Toxicology Program (NTP), Research Triangle Park, North Carolina; 2009. Available from: http://ntp.niehs.nih.gov/go/TS-M010098.
101. OECD (Organisation for Economic Co-operation and Development), 1997a. OECD Guidelines for the Testing of Chemicals, Section 4: Health Effects. Test No. 475: Mammalian Bone Marrow Chromosome Aberration Test. Adopted on 21 July 1997.
102. OECD (Organisation for Economic Co-operation and Development), 1997b. OECD Guidelines for the Testing of Chemicals, Section 4: Health Effects. Test No. 476: In vitro Mammalian Cell Gene Mutation Test. Adopted on 21 July 1997.
103. Olin KL, Stearns DM, Armstrong WH and Keen CL, 1994. Comparative retention/absorption of 51chromium (51Cr) from 51Cr chloride, 51Cr nicotinate and 51Cr picolinate in a rat model. Trace Elements and Electrolytes 11, 182–186.
104. Pasman WJ, Westerterp-Plantenga MS and Saris WH, 1997. The effectiveness of long-term supplementation of carbohydrate, chromium, fibre and caffeine on weight maintenance. International Journal of Obesity and Related Metabolic Disorders 21, 1143–1151.
105. Pittler MH, Stevinson C and Ernst E, 2003. Chromium picolinate for reducing body weight: Meta-analysis of randomized trials. International Journal of Obesity and Related Metabolic Disorders 27, 522–529.
106. Polansky MM, Bryden NA, Anderson RA, 1993. Effects of Form of Chromium on Chromium Absorption. FASEB J. 7, abstract no 442.
107. Preuss HG, Montamarry S, Echard B, Scheckenbach R and Bagchi D, 2001. Long-term effects of chromium, grape seed extract, and zinc on various metabolic parameters of rats. Molecular and Cellular Biochemistry 223, 95–102.
108. Rabinovitz H, Friedensohn A, Leibovitz A, Gabay G, Rocas C and Habot B, 2004. Effect of chromium supplementation on blood glucose and lipid levels in type II diabetes mellitus elderly patients. International Journal for Vitamin and Nutrition Research 74, 178–182.
109. Ravina A, Slezak L, Rubal A and Mirsky N, 1995. Clinical use of the trace element chromium(III) in the treatment of diabetes mellitus. Journal of Trace Elements in Medicine and Biology 8, 183–190.
110. Ravina A, Slezak L, Mirsky N, Bryden NA and Anderson RA, 1999. Reversal of corticosteroid-induced diabetes mellitus with supplemental chromium. Diabetic Medicine 16, 164–167.
111. Sahin N and Sahin K, 2001. Optimal dietary concentrations of vitamin C and chromium picolinate for alleviating the effect of low ambient temperature (6.2°C) on egg production, some egg characteristics, and nutrient digestibility in laying hens. Veterinární Medícina 46, 229–236.
112. Sahin K, Küçük O, Sahin N and Ozbey, 2001. Effects of dietary chromium supplementation on egg production, egg quality and serum concentrations of insulin, corticosterone, and some metabolites of Japanese quails. Nutrition Research 21, 1315–1321.
113. Sahin K, Ozbey O, Onderci M, Cikim G and Aysondu MH, 2002a. Chromium supplementation can alleviate negative effects of heat stress on egg production, egg quality and some serum metabolites of laying Japanese quail. Journal of Nutrition 132, 1265–1268.
114. Sahin K, Sahin N and Kucuk O, 2002b. Effects of dietary chromium and ascorbic acid supplementation on digestion of nutrients, serum antioxidant status, and mineral concentrations in laying hens reared at low ambient temperature. Biological Trace Element Research 87, 113–124.
115. San RHC, 2000. L5178YTK ± Mouse lymphoma mutagenesis assay, test article code # 81463, National Cancer Institute.
116. SCF (Scientific Committee on Food), 2003a. Opinion of the Scientific Committee on Food on the Revision of Reference Values for Nutrition Labelling (Opinion expressed on 5 March 2003). European Commission, Health and Consumer Protection Directorate-General, Directorate C – Scientific Opinions, C2 – Management of Scientific Committees II; Scientific Co-operation and Networks, Scientific Committee on Food (SCF), Brussels, Belgium. [SCF/CS/NUT/GEN/18 Final]. Available from: ec.europa.eu/food/fs/sc/scf/out171_en.pdf.
117. SCF (Scientific Committee on Food), 2003b. Opinion of the Scientific Committee on Food on the Tolerable Upper Intake Level of Trivalent Chromium (expressed in 4 April 2003). European Commission, Health and Consumer Protection Directorate-General, Directorate C – Scientific Opinions, C2 – Management of Scientific Committees II; Scientific Co-operation and Networks, Scientific Committee on Food (SCF), Brussels, Belgium. [SCF/CS/NUT/UPPLEV/67 Final]. Available from: ec.europa.eu/food/fs/sc/scf/out197_en.pdf.
118. Schroeder HA, Balassa JJ and, Vinton WH Jr., 1964. Chromium, lead, cadmium, nickel and titanium in mice: Effect on mortality, tumors and tissue levels. Journal of Nutrition 83, 239–250.
119. Schroeder HA, Balassa JJ and Vinton WH Jr., 1965. Chromium, cadmium and lead in rats: Effects on lifespan, tumors and tissue levels. Journal of Nutrition 86, 51–66.
120. Shinde UA and Goyal RK, 2003. Effect of chromium picolinate on histopathological alterations in STZ and neonatal STZ diabetic rats. Journal of Cellular and Molecular Medicine 7, 322–329.
121. Sims JL, Sikorski GW, 1982. Poly(adenosinediphoshoribose) polymerase inhibitors stimulate unscheduled deoxyribonucleid synthesis in normal human lymphocytes. Biochemistry 21, 1813–1812.
122. Slesinski RS, San R, Clarke J, Juturu V and Komorowski JR, 2004. Lack of mutagenicity of chromium picolinate in the cho/hgprt mutation assay: results from standard tests and a test with 48hour exposure. Environmental and Molecular Mutagenesis 44, 227 [Abstract No. 163].
123. Smyth HF, Carptenter CP Jr, Weil CS, Pozzani UC, Striegel JA and Nycum JS, 1969. Range-finding toxicity data: List VII. American Industrial Hygiene Association Journal 30, 470–476.
124. Speetjens JK, Collins RA, Vincent JB and Woski SA, 1999. The nutritional supplement chromium(III) tris(picolinate) cleaves DNA. Chemical Research in Toxicology 12, 483–287.
125. Stallings DM, Hepburn DDD, Hannah M, Vincent JB and O'Donnel J, 2006. Nutritional supplement chromium picolinate generates chromosomal aberrations and impedes progeny development in Drosophila melanogaster. Mutation Research 610, 101–113.
126. Stearns DM, Wise JP, Patierno SR and Wetterhahn KE, 1995. Chromium(III) picolinate produces chromosome damage in Chinese hamster ovary cells. FASEB Journal 9, 1643–1648.
127. Stearns DM, Silveira SM, Wolf KK and Luke AM, 2002. Chromium(III) tris(picolinate) is mutagenic at the hypoxanthine (guanine) phosphoribosyltransferase locus in Chinese hamster ovary cells. Mutation Research 513,135–142.
128. Stohs SJ and Bagchi D, 1995. Oxidative Mechanisms In The Toxicity of Metal Ions. Free Radical Biology and Medicine 18, 321–336.
129. Stout MD, Nyska A, Collins BJ, Witt KL, Kissling GE, Malarkey DE and Hooth MJ, 2009. Chronic toxicity and carcinogenicity studies of chromium picolinate monohydrate administered in feed to F344/N rats and B6C3F1 mice for 2 years. Food and Chemical Toxicology 47, 729–733.
130. Sun Y, Ramirez J, Woski SA and Vincent JB, 2000. The binding of trivalent chromium to low-molecular-weight chromium-binding substance (LMWCr) and the transfer of chromium from transferring and chromium picolinate to LMWCr. Journal of Biological Inorganic Chemistry: JBIC 5, 129–136.
131. Tan GY, Zheng SS, Zhang MH, Feng JH, Xie P and Bi JM, 2008. Study of oxidative damage in growing-finishing pigs with continuous excess dietary chromium picolinate intake. Biological Trace Element Research 126,129–40.
132. US DHHS (United States Department of Health and Human Services), 2003. The Third National Health and Nutrition Examination Survey (NHANES) 1988–1994 (NHANES III). Centre for Disease Control and Prevention (CDC), National Centre for Health Statistics (NCHS), Hyattsville, Maryland. Cited in: SCF, 2003b. Information available from: www.cdc.gov/nchs/about/major/nhanes/nh3data.htm.
133. USP (United States Pharmacopeia), 2008. Chromium picolinate. In: United States Pharmacopeia, 31st ed. And National Formulary, 26th ed. US Pharmacopeia (USP) Convention Inc., Rockville, Maryland, 923.
134. US Patent 5.194.615. Synthetic GTF Chromium Nicotinate Material and its Preparation, March 16, 1993.
135. Vernot EH, MacEwen JD, Haun CC and Kinkead ER, 1977. Acute toxicity and skin corrosion data for some organic and inorganic compounds and aqueous solutions. Toxicology and Applied Pharmacology 42, 417–423.
136. Vincent JB, 2000a. The biochemistry of chromium. Journal of Nutrition 130, 715–718.
137. Vincent JB, 2000b. Quest for the molecular mechanism of chromium action and its relationship to diabetes. Nutrition Reviews 58, 67–72.
138. Volpe SL, Huang HW, Larpadisorn K and Lesser II, 2001. Effect of chromium supplementation and exercise on body composition, resting metabolic rate and selected biochemical parameters in moderately obese women following an exercise program. Journal of the American College of Nutrition 20, 293–306.
139. Walker LS, Bemben MG, Bemben DA and Knehans AW, 1998. Chromium picolinate effects on body composition and muscular performance in wrestlers. Medicine and Science in Sports and Exercise 30, 1730–1737.
140. Wasser WG, Feldman NS and D'agti, VD, 1997a. Chronic renal failure after ingestion of over-the-counter chromium picolinate. Annals of Internal Medicine 126, 410.
141. Wasser WG, Yusuf SA and D'Agti VD, 1997. Over-the counter chromium and renal failure. Annals of Internal Medicine 127, 656.
142. Whittaker P, San RH, Clarke JJ, Seifried HE and Dunkel VC, 2005. Mutagenicity of chromium picolinate and its components in Salmonella typhimurium and L5178Y mouse lymphoma cells. Food and Chemical Toxicology 43, 1619–1625.
143. WHO (World Health Organisation), 1996. Trace elements in human nutrition and health (A report of a re-evaluation of the role of trace elements in human health and nutrition). Geneva.
144. Yeh GY, Eisenberg DM, Kaptchuk TJ and Phillips RS, 2003. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 26, 1277–1294 [and Data Supplement].